control of acute post operative pain.
Conditions
Interventions
Intervention 1: Intervention group: Oral duloxetine capsule 60 mg (Kharazmi Pharmacy) 2 hours before surgery(SNRI). Intervention 2: Control group: Placebo 2 hours before surgery.
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: Female age 35-65 Elective total abdominal hysterectomy ASA class 1 & 2
Exclusion criteria
Exclusion criteria: patient refusal Any alergic history with Duloxetine or other SNRIs surgery longer than 3 hours Postoperative cancer diagnosis or any other pelvic pathology during the operation Need additional surgery Any other incision than Pfannenstiel
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 30 min ,1 , 2 , 6 ,12 hours after surgery. Method of measurement: VAS score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: 0 to 12 hours postoperative. Method of measurement: Asking. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFahime Zamiri
Tehran University of Medical Sciences
Outcome results
None listed